Updated New Zealand cardiovascular disease risk-benefit prediction guide

doi:10.1136/bmj.320.7236.709

BMJ 2000;320:709-710 ( 11 March )

Education and debate

Updated New Zealand cardiovascular disease risk-benefit prediction guide

Editorial by Jackson

Rodney Jackson, professor of epidemiology.

Department of Community Health, University of Auckland, Auckland, New Zealand

rt.jackson@auckland.ac.nz

The first 150 words of the full text of this article appear below.

The benefits of drug treatment for patients with raised blood pressure or blood cholesterol are directly related to theirpretreatment risk of a cardiovascular disease event. ¹ ² Thisguide provides a simple quantitative method for assessing a person'srisk of cardiovascular disease and the likely benefits of loweringblood pressure or blood cholesterol with drugs. These instructionsand charts (figure) combine and update previous New Zealand cardiovasculardisease risk assessment charts. ³ ⁴ This is not a guidelinefor managing cardiovascular disease risk.

Table Removed (Available Only in the Full Text)

Assessing risk of a cardiovascular event over next five years

A cardiovascular event is defined as a death related to coronary disease, non-fatal myocardial infarction, new angina, fatalor non-fatal stroke or transient ischaemic attack, or the developmentof congestive heart failure or peripheral vasculardisease.

Estimating risk of cardiovascular disease
In some people, a high risk (>20% in fiveyears) can be assumed on the basis of history, symptoms, or signsalone, including symptomatic cardiovascular disease (as definedabove), . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Article

Guidelines on preventing cardiovascular disease in clinical practice: Rodney Jackson
BMJ 2000 320: 659-661. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

D'Agostino, R. B. Sr, Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., Kannel, W. B. (2008). General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation 117: 743-753 [Abstract] [Full text]
Bolland, M. J, Grey, A. B, Ames, R. W, Mason, B. H, Horne, A. M, Gamble, G. D, Reid, I. R (2007). The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am. J. Clin. Nutr. 86: 959-964 [Abstract] [Full text]
Brindle, P, Beswick, A, Fahey, T, Ebrahim, S (2006). Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 92: 1752-1759 [Abstract] [Full text]
El Fakiri, F, Bruijnzeels, M A, Hoes, A W (2006). Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk. Heart 92: 741-745 [Abstract] [Full text]
Vasan, R. S. (2006). Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations. Circulation 113: 2335-2362 [Full text]
Hak, E, Bont, J, Hoes, A., Verheij, T. (2005). Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam Pract 22: 375-380 [Abstract] [Full text]
Whiteman, D. C., Green, A. C. (2005). A Risk Prediction Tool for Melanoma?. Cancer Epidemiol. Biomarkers Prev. 14: 761-763 [Full text]
Rodriguez-Manas, L., Castro, M., Manzarbeitia, J. (2005). Review: Cardiovascular risk and diabetes in old people. British Journal of Diabetes & Vascular Disease 5: 7-11 [Abstract]
Hense, H.-W. (2004). Observations, predictions and decisions--assessing cardiovascular risk assessment. Int J Epidemiol 33: 235-239 [Full text]
Ciardullo, A., Azzolini, L, Bevini, M, Cadioli, T, Daghio, M., Guidetti, P, Lorenzetti, M, Malavasi, P, Morellini, A, Carapezzi, C (2004). A diagnosis of left ventricular hypertrophy on ECG is associated with a high cardiovascular risk: findings from a 40- to 69-year-old cohort in general practice. Fam Pract 21: 63-65 [Abstract] [Full text]
Brindle, P., Emberson, J., Lampe, F., Walker, M., Whincup, P., Fahey, T., Ebrahim, S. (2003). Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327: 1267- [Abstract] [Full text]
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., Fayad, Z., Stone, P. H., Waxman, S., Raggi, P., Madjid, M., Zarrabi, A., Burke, A., Yuan, C., Fitzgerald, P. J., Siscovick, D. S., de Korte, C. L., Aikawa, M., Airaksinen, K. E. J., Assmann, G., Becker, C. R., Chesebro, J. H., Farb, A., Galis, Z. S., Jackson, C., Jang, I.-K., Koenig, W., Lodder, R. A., March, K., Demirovic, J., Navab, M., Priori, S. G., Rekhter, M. D., Bahr, R., Grundy, S. M., Mehran, R., Colombo, A., Boerwinkle, E., Ballantyne, C., Insull, W. Jr, Schwartz, R. S., Vogel, R., Serruys, P. W., Hansson, G. K., Faxon, D. P., Kaul, S., Drexler, H., Greenland, P., Muller, J. E., Virmani, R., Ridker, P. M, Zipes, D. P., Shah, P. K., Willerson, J. T. (2003). From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II. Circulation 108: 1772-1778 [Abstract] [Full text]
Marrugat, J, D'Agostino, R, Sullivan, L, Elosua, R, Wilson, P, Ordovas, J, Solanas, P, Cordon, F, Ramos, R, Sala, J, Masia, R, Kannel, W B (2003). An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J. Epidemiol. Community Health 57: 634-638 [Abstract] [Full text]
Hall, L M L, Jung, R T, Leese, G P (2003). Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 326: 251-252 [Full text]
Cappuccio, F. P, Oakeshott, P., Strazzullo, P., Kerry, S. M (2002). Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study. BMJ 325: 1271-1271 [Abstract] [Full text]
Campbell, N. R.C., Drouin, D., Feldman, R. D. (2002). The 2001 Canadian hypertension recommendations: take-home messages. CMAJ 167: 661-668 [Full text]
(2002). Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?. Heart 88: 222-228 [Abstract] [Full text]
Marteau, T. M, Kinmonth, A. L. (2002). Screening for cardiovascular risk: public health imperative or matter for individual informed choice?. BMJ 325: 78-80 [Full text]
Marchioli, R, Avanzini, F, Barzi, F, Chieffo, C, Di Castelnuovo, A, Franzosi, M.G, Geraci, E, Maggioni, A.P, Marfisi, R.M, Mininni, N, Nicolosi, G.L, Santini, M, Schweiger, C, Tavazzi, L, Tognoni, G, Valagussa, F, on behalf of GISSI-Prevenzione Investigators, (2001). Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart. Eur Heart J 22: 2085-2103 [Abstract]
Wood, D. (2001). Asymptomatic individuals - risk stratification in the prevention of coronary heart disease. Br Med Bull 59: 3-16 [Abstract] [Full text]
SEDGWICK, J. E C (2001). Absolute, attributable, and relative risk in the management of coronary heart disease. Heart 85: 491-492 [Full text]
Jones, A F, Walker, J, Jewkes, C, Game, F L, Bartlett, W A, Marshall, T, Bayly, G R (2001). Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart 85: 37-43 [Abstract] [Full text]
Jackson, R. (2000). Guidelines on preventing cardiovascular disease in clinical practice. BMJ 320: 659-661 [Full text]